Prof. Carlo Torti graduated in Medicine from the University of Pavia in 1994. He obtained his specialty in Infectious Diseases in 2000 from the University of Brescia where he worked as Consultant Physician and Assistant Professor in Infectious Diseases from 2001 to 2012. He was appointed Director of the Infectious and Tropical Diseases Unit at the University “Magna Graecia” in Catanzaro in 2012. He is Associate Professor in the same University. He also served as Honorary Lecturer at the University of Makerere (Uganda). His main areas of interests are: general Infectious Diseases, viro-immunological and clinical outcomes of antiretroviral treatment, HIV drug resistance, and co-infection of HIV with hepatitis viruses. He recently expanded his research interests to include HCV epidemiology and management. He has published more than 200 papers in peer-reviewed international journals, participated in many international clinical trials, and he is member of the Steering Committee of several cohort studies (including COHERE). Prof. Carlo Torti is a Section Editor for BMC Infection Diseases and served as Editor and Peer Reviewer for several International Journals including The Lancet, Hepatology, Journal of Antimicrobial Chemotherapy and others.
Prof. Erich Schmutzhard graduated from University Innsbruck in 1974, he was trained in Tropical Medicine in Liverpool, UK. After 4 years of field work in Tanzania he specialized in Neurology and Critical Care Medicine at the Universities of Innsbruck, Austria and Bangkok (Mahidol University), Thailand. Since the late eighties he was lecturer in Tropical Neurology and Critrical Care Neurology at the University Innsbruck, Austria. In 2000 he was appointed Professor for Neurocritical Care Medicine in Innsbruck, in 2002 Guest Professor in Ossijek, Croatia, in 2006 Honorary Professor in Tripoli, Lybia. He is Head of the European Academy of Neurology (EAN) Task Force: „Neurology in Africa“, Austria's delegate to the World Federation of Neurology (WFN) and Coordinator for the Innsbruck Medical University to ASEA Uninet and Eurasia-Pacific University networks. His major research interests are „Tropical Neurology and Neuroepidemiology“ and „Clinical and Experimental Critical Care Neurology“. Major research fields combining these two fields of interest are „Cerebral Malaria, longterm sequelae“ and „experimental murine Cerebral Malaria“, as well as „Epilepsy in Africa“, in particular „Nodding syndrome in Tanzania and Uganda“. He has published more than 300 papers in peer-reviewed international journals and participated in many international clinical trials.
Tropical Neurology and Neuroepidemiology,Clinical and Experimental Critical Care Neurology,Cerebral Malaria, longterm sequelae,experimental murine Cerebral Malaria.
Marcel Tanner obtained a PhD on medical biology from the University of Basel and a MPH from the University of London. He is Director of the Swiss Tropical and Public Health Institute and Professor of Epidemiology and Medical Parasitology at the University of Basel and at the Federal Institute of Technology.Since 1977 his research has ranged from basic research on the cell biology and immunology of malaria, schistosomiasis, trypanosomiasis and filariasis to epidemiological and public health research on risk assessment, vulnerability, health impact and district health planning. His research, teaching, and health planning expertise are based on substantial long term experience from working in rural and urban areas in Africa (mainly the United Republic of Tanzania, Chad, Burkina Faso and Côte d’Ivoire) and Asia (China, Thailand, Laos). He was co-investigator and coordinator of the first African malaria vaccine trial in 1992 and participated as co-principal investigator in several major intervention trials on malaria (iron supplementation, intermittent preventive treatment) and schistosomiasis. Besides research, capacity building and North-South partnerships are a main interest as reflected in the development of the Ifakara Health Institute in the United Republic of Tanzania.
Cell biology and immunology of malaria, schistosomiasis, trypanosomiasis and filariasis to epidemiological and public health research on risk assessment, vulnerability, health impact and district health planning
Srivicha Krudsood is the Deputy Director, WHO CC for Clinical Management of Malaria and Professor of Mahidol University.Her field of expertise are Clinical trial of anti-malarial drugs and Clinical management of malaria.She have many publication in different journals.She also wrote many books like Atlas of Medical Parasitology,Text book of Travel Medicine etc.
Clinical trial of anti-malarial drugs,Clinical management of malaria
As a pediatrician, with special interest in infectious disease epidemiology and public health, Dr. Bassat has attempted to combine his clinical work with biomedical research in those diseases that most affect the poor and vulnerable. Originally based in Manhiça, Mozambique, he worked there as a pediatrician and a clinical researcher, participating in different clinical trials related to malaria prevention and treatment. He was also particularly interested in the study of the burden, trends and characterization of malaria in children admitted to hospital, and the overlapping symptomatology between malaria and other common infectious diseases. While his work was initially focused in P. falciparum malaria and children, he has widened his scope of interest to the study of Plasmodium vivax. In recent years, he has also spent important efforts describing the epidemiology and control of Yaws in Papua New Guinea. He has also conducted work on the description of the epidemiology and etiology of respiratory infections (viral and bacterial) both in Mozambique and in Morocco. Currently, his main project is related to the validation and implementation of Minimally Invasive Autopsy (MIA) tools for the post-mortem investigation of Causes of death in the developing world.
P. falciparum malaria and children,epidemiology and control of Yaws in Papua New Guinea,validation and implementation of Minimally Invasive Autopsy (MIA) tools for the post-mortem investigation of Causes of death in the developing world.
Professor Shigeyuki Kano, MD, PhD is Director of the Department of Tropical Medicine and Malaria, Research Institute, National Center for Global Health and Medicine, Japan. He is President of Japanese Society of Tropical Medicine, and currently, Board Member of Japan Association for International Health, Japanese Society of Travel and Health, Japanese Society of Clinical Parasitology, the Japanese Society of Parasitology, member of ASTMH, Fellow of RSTMH, and Expanded Board member of International Federation for Tropical Medicine (IFTM). He has been serving as an advisor of Japan International Cooperation Agency (JICA) for the malaria control project under Japanese ODA or Global Fund. He also belongs to Institut Pasteur du Laos (IPL) as Head of Lao-Japan Parasitology Laboratory under SATREPS (JICA/AMED) Project, in Vientiane, Lao PDR.
Dr. Kain’s research efforts are focused on developing a translational research program that characterizes host-parasite interactions responsible for major global infectious disease threats, particularly as they pertain to women and children. Dr Kain’s efforts are also focused on global equity, knowledge sharing and education, including the transfer of appropriate technologies and the training of research scientists in the developing world, enabling and empowering them to address their own problems in a sustainable fashion.
To develop a translational research program that characterizes host-parasite interactions responsible for major global health threats such as malaria and HIV. To determine the molecular basis for adverse clinical outcomes in life-threatening inefctions and to translate this knowledge into novel therapeutic interventions.